New Yumizen G coagulation analysers and reagent range designed to suit any laboratory
HORIBA UK Medical has announced a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.
Marking a milestone in its new product development programme, the Yumizen G range extends HORIBA Medical’s haematology portfolio into the complementary field of haemostasis, a new discipline for the company.
In combination with specifically-developed and optimised ready-to-use reagents; Yumizen G provides a high-quality and cost-effective range of haemostasis solutions that will fit any laboratory size or requirement. The range includes:
Commenting on the launch, Cleve Wright, director of HORIBA Medical UK, said: “By leveraging our extensive expertise in the haematology field, we have significantly broadened our scope in blood disease analysis into a complementary discipline.
“This means that HORIBA Medical is now able to offer customers a dedicated and specific blood analysis solution to suit any laboratory.”